Phase 1b randomized controlled study of short course topical recombinant human nerve growth factor (rhNGF) for neuroenhancement in glaucoma: safety, tolerability and efficacy measure outcomes
Keyword(s):
Phase 1B
◽
Keyword(s):
1989 ◽
Vol 264
(20)
◽
pp. 11714-11720
◽
Keyword(s):
1997 ◽
Vol 76
(1)
◽
pp. 75-81
◽
Keyword(s):
Keyword(s):
1995 ◽
Vol 23
(16)
◽
pp. 3198-3205
◽
Keyword(s):